Compliance with a three-day course of artesunate-mefloquine combination and baseline anti-malarial treatment in an area of Thailand with highly multidrug resistant falciparum malaria

BACKGROUND: Artemisinin-based combination therapy (ACT) is presently recommended by the World Health Organization as first-line treatment for uncomplicated Plasmodium falciparum malaria in several countries, as a mean of prolonging the effectiveness of first-line malaria treatment regimens. A three-...

Descripción completa

Detalles Bibliográficos
Autores principales: Congpuong, Kanungnit, Bualombai, Pongwit, Banmairuroi, Vick, Na-Bangchang, Kesara
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829592/
https://www.ncbi.nlm.nih.gov/pubmed/20132537
http://dx.doi.org/10.1186/1475-2875-9-43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829592/
https://www.ncbi.nlm.nih.gov/pubmed/20132537
http://dx.doi.org/10.1186/1475-2875-9-43

Ejemplares similares